Literature DB >> 21849340

Distinct neuropsychological profiles correspond to distribution of cortical thinning in inherited prion disease caused by insertional mutation.

K Alner1, H Hyare, S Mead, P Rudge, S Wroe, J D Rohrer, G R Ridgway, S Ourselin, M Clarkson, H Hunt, N C Fox, T Webb, J Collinge, L Cipolotti.   

Abstract

BACKGROUND: The human prion diseases are a group of universally fatal neurodegenerative disorders associated with the auto-catalytic misfolding of the normal cell surface prion protein (PrP). Mutations causative of inherited human prion disease (IPD) include an insertion of six additional octapeptide repeats (6-OPRI) and a missense mutation (P102L) with large families segregating for each mutation residing in southern England. Here we report for the first time the neuropsychological and clinical assessments in these two groups.
METHOD: The cognitive profiles addressing all major domains were obtained for 26 patients (18 6-OPRI, 8 P102L) and the cortical thickness determined using 1.5T MRI in a subset of 10 (six 6-OPRI, four P102L).
RESULTS: The cognitive profiles were different in patients with the two mutations in the symptomatic phase of the disease. The 6-OPRI group had lower premorbid optimal levels of functioning (assessed on the NART) than the P102L group. In the symptomatic phase of the disease the 6-OPRI patients had significantly more executive dysfunction than the P102L group and were more impaired on tests of perception and nominal functions. There was anecdotal evidence of low premorbid social performance in the 6-OPRI but not P102L patients. Cortical thinning distribution correlated with the neuropsychological profile in the 6-OPRI group principally involving the parietal, occipital and posterior frontal regions. The small number of patients in the P102L group precluded statistical comparison between the groups.
CONCLUSIONS: The 6-OPRI patients had more widespread and severe cognitive dysfunction than the P102L group and this correlated with cortical thinning distribution.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21849340     DOI: 10.1136/jnnp-2011-300167

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  9 in total

1.  Imaging of the 6-OPRI mutation prion disease: an entity distinct from typical Creutzfeldt-Jakob disease?

Authors:  A J Degnan; L M Levy
Journal:  AJNR Am J Neuroradiol       Date:  2013-03-28       Impact factor: 3.825

2.  Predictive testing for inherited prion disease: report of 22 years experience.

Authors:  Jane Owen; Jon Beck; Tracy Campbell; Gary Adamson; Michele Gorham; Andrew Thompson; Sarah Smithson; Elizabeth Rosser; Peter Rudge; John Collinge; Simon Mead
Journal:  Eur J Hum Genet       Date:  2014-04-09       Impact factor: 4.246

3.  Selective vulnerability to atrophy in sporadic Creutzfeldt-Jakob disease.

Authors:  Kyan Younes; Julio C Rojas; Amy Wolf; Goh M Sheng-Yang; Matteo Paoletti; Gianina Toller; Eduardo Caverzasi; Maria Luisa Mandelli; Ignacio Illán-Gala; Joel H Kramer; Yann Cobigo; Bruce L Miller; Howard J Rosen; Michael D Geschwind
Journal:  Ann Clin Transl Neurol       Date:  2021-05-05       Impact factor: 4.511

4.  The language disorder of prion disease is characteristic of a dynamic aphasia and is rarely an isolated clinical feature.

Authors:  Diana Caine; Akin Nihat; Philippa Crabb; Peter Rudge; Lisa Cipolotti; John Collinge; Simon Mead
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

5.  Prion disease diagnosis using subject-specific imaging biomarkers within a multi-kernel Gaussian process.

Authors:  Liane S Canas; Carole H Sudre; Enrico De Vita; Akin Nihat; Tze How Mok; Catherine F Slattery; Ross W Paterson; Alexander J M Foulkes; Harpreet Hyare; M Jorge Cardoso; John Thornton; Jonathan M Schott; Frederik Barkhof; John Collinge; Sébastien Ourselin; Simon Mead; Marc Modat
Journal:  Neuroimage Clin       Date:  2019-10-25       Impact factor: 4.881

6.  Multiparameter MR imaging in the 6-OPRI variant of inherited prion disease.

Authors:  E De Vita; G R Ridgway; R I Scahill; D Caine; P Rudge; T A Yousry; S Mead; J Collinge; H R Jäger; J S Thornton; H Hyare
Journal:  AJNR Am J Neuroradiol       Date:  2013-03-28       Impact factor: 3.825

7.  Protease-sensitive prions with 144-bp insertion mutations.

Authors:  Xiangzhu Xiao; Ignazio Cali; Zhiqian Dong; Gianfranco Puoti; Jue Yuan; Liuting Qing; Heming Wang; Qingzhong Kong; Pierluigi Gambetti; Wen-Quan Zou
Journal:  Aging (Albany NY)       Date:  2013-03       Impact factor: 5.682

8.  A comparison of FreeSurfer-generated data with and without manual intervention.

Authors:  Christopher S McCarthy; Avinash Ramprashad; Carlie Thompson; Jo-Anna Botti; Ioana L Coman; Wendy R Kates
Journal:  Front Neurosci       Date:  2015-10-21       Impact factor: 4.677

9.  Neuroanatomical correlates of prion disease progression - a 3T longitudinal voxel-based morphometry study.

Authors:  Enrico De Vita; Gerard R Ridgway; Mark J White; Marie-Claire Porter; Diana Caine; Peter Rudge; John Collinge; Tarek A Yousry; Hans Rolf Jager; Simon Mead; John S Thornton; Harpreet Hyare
Journal:  Neuroimage Clin       Date:  2016-11-02       Impact factor: 4.881

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.